Literature DB >> 19211740

Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization.

William L Ince1, Patrick R Harrington, Gretja L Schnell, Milloni Patel-Chhabra, Christina L Burch, Prema Menezes, Richard W Price, Joseph J Eron, Ronald I Swanstrom.   

Abstract

A distinctive feature of chronic human immunodeficiency virus type 1 (HIV-1) infection is the presence of multiple coexisting genetic variants, or subpopulations, that comprise the HIV-1 population detected in the peripheral blood. Analysis of HIV-1 RNA decay dynamics during the initiation of highly active antiretroviral therapy (HAART) has been a valuable tool for modeling the life span of infected cells that produce the bulk HIV-1 population. However, different HIV-1 target cells may have different turnover rates, and it is not clear whether the bulk HIV-1 RNA decay rate actually represents a composite of the decay rates of viral subpopulations compartmentalized in different cellular subsets with different life spans. Using heteroduplex tracking assays targeting the highly variable V3 or V4-V5 regions of the HIV-1 env gene in eight subjects, we found that all detectable coexisting HIV-1 variants in the peripheral blood generally decayed at similar rates during the initiation of HAART, suggesting that all of the variants were produced by cells with similar life spans. Furthermore, single genome amplification and coreceptor phenotyping revealed that in two subjects coexisting HIV-1 variants with distinct CXCR4 or CCR5 coreceptor phenotypes decayed with similar rates. Also, in nine additional subjects, recombination and a lack of genetic compartmentalization between X4 and R5 variants were observed, suggesting an overlap in host cell range. Our results suggest that the HIV-1 env subpopulations detectable in the peripheral blood are produced by cells with similar life spans and are not genetically isolated within particular cell types.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19211740      PMCID: PMC2668457          DOI: 10.1128/JVI.02486-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  102 in total

1.  Coreceptor choice and T cell depletion by R5, X4, and R5X4 HIV-1 variants in CCR5-deficient (CCR5delta32) and normal human lymphoid tissue.

Authors:  N Malkevitch; D H McDermott; Y Yi; J C Grivel; D Schols; E De Clercq; P M Murphy; S Glushakova; R G Collman; L Margolis
Journal:  Virology       Date:  2001-03-15       Impact factor: 3.616

2.  Genetic drift and within-host metapopulation dynamics of HIV-1 infection.

Authors:  S D Frost; M J Dumaurier; S Wain-Hobson; A J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

3.  Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection.

Authors:  Eric Delwart; Magdalena Magierowska; Maya Royz; Brian Foley; Lorraine Peddada; Richard Smith; Charles Heldebrant; Andrew Conrad; Michael Busch
Journal:  AIDS       Date:  2002-01-25       Impact factor: 4.177

4.  Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.

Authors:  Tuofu Zhu; David Muthui; Sarah Holte; David Nickle; Feng Feng; Scott Brodie; Yon Hwangbo; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.

Authors:  J K Nicholson; S W Browning; R L Hengel; E Lew; L E Gallagher; D Rimland; J S McDougal
Journal:  J Acquir Immune Defic Syndr       Date:  2001-06-01       Impact factor: 3.731

6.  Immune-mediated positive selection drives human immunodeficiency virus type 1 molecular variation and predicts disease duration.

Authors:  Howard A Ross; Allen G Rodrigo
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Preferential suppression of CXCR4-specific strains of HIV-1 by antiviral therapy.

Authors:  S Philpott; B Weiser; K Anastos; C M Kitchen; E Robison; W A Meyer; H S Sacks; U Mathur-Wagh; C Brunner; H Burger
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

8.  Highly restricted spread of HIV-1 and multiply infected cells within splenic germinal centers.

Authors:  S Gratton; R Cheynier; M J Dumaurier; E Oksenhendler; S Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

9.  Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.

Authors:  Paul R Gorry; Joann Taylor; Geoffrey H Holm; Andrew Mehle; Tom Morgan; Mark Cayabyab; Michael Farzan; Hui Wang; Jeanne E Bell; Kevin Kunstman; John P Moore; Steven M Wolinsky; Dana Gabuzda
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

10.  A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics.

Authors:  W Resch; N Parkin; E L Stuelke; T Watkins; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

View more
  11 in total

1.  Inferring viral population structures using heteroduplex mobility and DNA sequence analyses.

Authors:  Raj Shankarappa; James I Mullins
Journal:  J Virol Methods       Date:  2013-08-29       Impact factor: 2.014

2.  HIV variability in the liver and evidence of possible compartmentalization.

Authors:  Jason T Blackard; Gang Ma; Christina M Martin; Susan D Rouster; M Tarek Shata; Kenneth E Sherman
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-04       Impact factor: 2.205

3.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

Review 4.  HIV-1 target cells in the CNS.

Authors:  Sarah B Joseph; Kathryn T Arrildt; Christa B Sturdevant; Ronald Swanstrom
Journal:  J Neurovirol       Date:  2014-09-19       Impact factor: 2.643

Review 5.  The HIV-1 env protein: a coat of many colors.

Authors:  Kathryn Twigg Arrildt; Sarah Beth Joseph; Ronald Swanstrom
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

6.  Envelope gene evolution and HIV-1 neuropathogenesis.

Authors:  Fabián J Vázquez-Santiago; Vanessa Rivera-Amill
Journal:  J Neuroinfect Dis       Date:  2015-08-20

7.  Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model.

Authors:  William L Ince; Liguo Zhang; Qi Jiang; Kathryn Arrildt; Lishan Su; Ronald Swanstrom
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

8.  HIV-1 Virological Synapse: Live Imaging of Transmission.

Authors:  Jerome Feldmann; Olivier Schwartz
Journal:  Viruses       Date:  2010-08-12       Impact factor: 5.818

9.  Varied sensitivity to therapy of HIV-1 strains in CD4+ lymphocyte sub-populations upon ART initiation.

Authors:  Edwin J Heeregrave; Mark J Geels; Elly Baan; Renee M van der Sluis; William A Paxton; Georgios Pollakis
Journal:  AIDS Res Ther       Date:  2010-12-06       Impact factor: 2.250

10.  Daily sampling of an HIV-1 patient with slowly progressing disease displays persistence of multiple env subpopulations consistent with neutrality.

Authors:  Helena Skar; Ryan N Gutenkunst; Karin Wilbe Ramsay; Annette Alaeus; Jan Albert; Thomas Leitner
Journal:  PLoS One       Date:  2011-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.